Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity

Head and Neck

Volumn 36, Issue 1, 2014, Pages 34-42

  Colevas, A Dimitrios ^a  

^a STANFORD CANCER INSTITUTE   (United States)

Author keywords

incidence trends; oropharyngeal carcinoma; population based analysis; socioeconomic status; squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; SEX; SOCIAL STATUS;

INCIDENCE TRENDS; OROPHARYNGEAL CARCINOMA; POPULATION-BASED ANALYSIS; SOCIOECONOMIC STATUS; SQUAMOUS CELL CARCINOMA;

ADULT; AGE DISTRIBUTION; AGED; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 84890442524     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23253     Document Type: Article

References (37)

1. American Cancer Society (ACS). Cancer Facts & Figures 2011. Atlanta, GA: ACS; 2011. Online.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. National Cancer Institute (NCI). NCI Factsheet: Head and Neck Cancer: Questions and Answers. Bethesda, MD: NCI; 2011.
4. Braakhuis BJ, Visser O, Leemans CR,. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: increasing incidence, but not in young adults. Oral Oncol 2009; 45: e85-e89.
5. Frisch M, Hjalgrim H, Jaeger AB, et al. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000; 11: 489-495.
6. Hammarstedt L, Dahlstrand H, Lindquist D, et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007; 127: 988-992.
7. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
8. Junor EJ, Kerr GR, Brewster DH,. Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men. BMJ 2010; 340: c2512 (abstract).
9. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
10. Chaudhary AK, Singh M, Sundaram S, et al. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 2009; 1: 22.
11. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998; 58: 5-13.
12. Jung AC, Briolat J, Millon R, et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010; 126: 1882-1894.
13. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131.
14. D'Souza G, Agrawal Y, Halpern J, et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269.
15. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
16. Schwartz SR, Yueh B, McDougall JK, et al. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001; 125: 1-9.
17. Smith EM, Wang D, Kim Y, et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 2008; 44: 133-142.
18. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
19. Brawley OW,. Oropharyngeal cancer, race, and the human papillomavirus. Cancer Prev Res 2009; 2: 769-772.
20. Stamataki P, Papazafiropoulou A, Elefsiniotis I, et al. Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic. BMC infectious diseases. 2010; 10: 27 (abstract).
21. Silva KC, Rosa ML, Moyse N, et al. Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2009; 104: 885-891.
22. Ortiz M, Torres M, Munoz L, et al. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006; 44: 1428-1434.
23. Camargo M, Soto-De Leon SC, Sanchez R, et al. Frequency of human papillomavirus infection, coinfection, and association with different risk factors in Colombia. Ann Epidemiol 2011; 21: 204-213.
24. Akogbe GO, Ajidahun A, Sirak B, et al. Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int J Cancer 2012; 131: E282-E291.
25. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703.
26. Yost K, Perkins C, Cohen R, et al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001; 12: 703-711.
27. Chang ET, Zheng T, Weir EG, et al. Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1361-1370.
28. Gutensohn N, Cole P,. Childhood social environment and Hodgkin's disease. N Engl J Med 1981; 304: 135-140.
29. California Department of Public Health. California Cancer Registry Facts & Figures 2011. San Diego, CA: California Cancer Registry; 2011.
30. National Cancer Institute (NCI). Surveillance Epidemiology and End Results SEER*Stat Software, version 7.0.5, 2011.
31. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
32. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res 2009; 2: 776-781.
33. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004; 100: 1035-1044.
34. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
35. Gillison ML, D'souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420.
36. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
37. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009; 119: 1542-1549.